biomedicina slovenica

id=190939 : 1

1. Ciuleanu Tudor; Ocvirk Janja
   A randomized, open-label CECOG phase II study evaluating the efficacy and safety of FOLFOX6 + cetuximab versus FOLFIRI + cetuximab as first-line therapy in patients (pts) with metastatic colorectal cancer (mCRC)
   2008 ►

New search      Comments      Top of page Institute for Biostatistics and Medical Informatics